BTIG Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)

Go back to BTIG Reiterates Buy Rating on Ovid Therapeutics Inc (OVID)
(NASDAQ: OVID) Delayed: 2.83 +0.03 (1.07%)
Previous Close $2.80    52 Week High
Open $2.80    52 Week Low
Day High $2.87    P/E N/A 
Day Low $2.75    EPS
Volume 1,240,941